Differences in lung cancer risk between men and women: Examination of the evidence

Journal of the National Cancer Institute

Volumn 88, Issue 3-4, 1996, Pages 183-192

  Zang, Edith A ^a   Wynder, Ernst L ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING;

ADENOCARCINOMA; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PLANTS, TOXIC; RISK FACTORS; SEX FACTORS; SMOKING; TOBACCO;

EID: 0030056868     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.3-4.183     Document Type: Article

References (54)

1. Healthy People 2000 Review. Washington (DC): US Department of Health and Human Services, Public Health Service, 1992:102.
2. Ries LA, Miller BA, Hankey BF, et al., editors. SEER cancer statistics review. 1973-1991: tables and graphs. Bethesda (MD): National Cancer Institute. NIH Publication No. 94-2789, 1994:264.
3. American Cancer Society. Cancer facts and figures - 1994. Atlanta (GA): American Cancer Society, 1994:1-28.
4. Ernster VL. The epidemiology of lung cancer in women. Ann Epidemiol 1994;4:102-10.
5. Lubin JH, Blot WJ. Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst 1984;73:383-9.
6. McDuffie HH, Klaassen DJ, Dosman JA. Female-male differences in patients with primary lung cancer. Cancer 1987;59:1825-30.
7. McDuffie HH, Klaassen DJ, Dosman JA. Men, women and primary lung cancer - a Saskatchewan personal interview study. J Clin Epidemiol 1991; 44:537-44.
8. Zang EA, Wynder EL. Cumulative tar exposure. A new index foi estimating lung cancer risk among cigarette smokers. Cancer 1992;70:69-76.
9. Brownson RC, Chang JC, Davis JR. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology 1992;3:61-4.
10. Risch HA, Howe GR, Jain M, Burch DJ, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type [sec comment citations in Medline]. Am J Epidemiol 1993;138:281-93.
11. Osann KE, Anton-Culver H. Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993; 54:44-8.
12. Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP. Methodology for evaluating incidence of second primary cancers with application to smoking-related cancers from S.E.E.R. Am J Epidemiol 1995;142:653-65.
13. Dwyer T, Blizzard L, Shugg D, Hill D, Ansari MZ Higher lung cancel-rates in young women than young men: Tasmania, 1983 to 1992. Cancer Causes Control 1994;5:351-8.
14. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res 1977,37:4608-22.
15. Orleans CT, Schoenbach VJ, Salmon MA, Strecher VJ, Kalsbeek W, Quade D, et al. A survey of smoking and quitting patterns among black Americans. Am J Pubulic Health 1989;79:176-81.
16. Kalow W, Goedde HW, Agarwal DP, editors Ethnic differences in reactions to drugs and other xenobiotics. New York: Alan Liss, Inc., 1986.
17. Kreyberg L. Histological lung cancer types. Oslo: Norwegian Universities Press, 1962.
18. Federal Trade Register. Part IV, Federal Trade Commission. "Tar," nicotine and carbon monoxide content of domestic cigarettes. Washington (DC): US Govt Print Off, 1977 and 1988.
19. Cox DR. Analysis of binary data. London. Methuen & Co., 1977.
20. Gart JJ. On the combination of relative risks. Biometrics 1962;18.601-10.
21. Sheehe PR Combination of log relative risk in retrospective studies of disease. Am J Public Health Nation's Health 1966;56:1745-50.
22. Wilcox AJ. Re: Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type [letter]. Am J Epidemiol 1994,140:186.
23. Hoover DR. Re: Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type [letter] [see comment citation in Medline]. Am J Epidemiol 1994;140:186-7.
24. Zang EA, Wynder EL. The association between body mass index and the relative frequencies of diseases in a sample of hospitalized patients. Nutr Cancer 1994;21:247-61.
25. Herning RI, Jones RT, Bachman J, Mines AH. Puff volume increases when low-nicotine cigarettes are smoked. Br Med J Clin Res 1991;283:187-9.
26. Morabia A, Moore M, Wynder EL. Reproducibility of food frequency measurements and inferences from a case-control study. Epidemiology 1990;1:305-10
27. Hoffmann D, Djordjevic MV, Brunnemann KD. Changes in cigarette design and composition over time and how they influence the yields of smoke constituents. J Smoking-Related Dis 1995;6:9-23.
28. Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1991; 1:29-34.
29. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers [see comment citation in Medline]. J Natl Cancer Inst 1993;85:457-64.
30. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976;2:1525-36.
31. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 1980;280:967-71.
32. Taubes G. Claim of higher risk for women smokers attacked [news] [see comment citation in Medline]. Science 1993;262:1375.
33. Beckett AH, Gorrod JW, Jenner P. The effect of smoking on nicotine metabolism in vivo in man. J Pharm Pharmacol 1971;23(Suppl):62S-7S.
34. Benowitz NL, Jacob P 3d. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
35. Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines in human cancer. Cancer Surv 1989;8:273-94.
36. Holck HG, Kanan MA, Mills LM, Smith EL. Studies upon the sex-difference in rats in tolerance to certain barbiturates and to nicotine. J Pharm Exp Ther 1937;60:323-46.
37. Rosecrans JA, Schechter MD. Brain area nicotine levels in male and female rats of two strains. Arch Int Pharmacodyn Ther 1972;196:46-54.
38. Kyerematen GA, Owens GF, Chattopadhyay B, deBethizy JD, Vesell ES. Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro. Drug Metab Dispos 1988;16:823-8.
39. Seaton M, Kyerematen GA, Morgan M, Jeszenka EV, Vesell ES. Nicotine metabolism in stumptailed macaques, Macaca arctoides. Drug Metab Dispos 1991;19:946-54.
40. Klein AE, Gorrod JW. Age as a factor in the metabolism of nicotine. Eur J Drug Metab Pharma 1978;1:51-8.
41. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991;4:391-407.
42. Kato R. Sex-related differences in drug metabolism. Drug Metab Rev 1974;3:1-32.
43. Schenkman JB, Frey I, Remmer H, Estabrook RW. Sex differences in drug metabolism by rat liver microsomes. Mol Pharmacol 1967;3:516-25
44. Piekoszewski W, Brandys J, Lipniak M. Studies on sex related differences in elimination of theophylline in the rat after pretreatment with phenobarbital, chrysene, Aroclor 1254 or Iindane. Acta Pol Pharm 1991;48:9-12.
45. Lee RP, Forkert PG. Pulmonary CYP2E1 bioactivates 1,1-dichloroethylene in male and female mice. J Pharmacol Exp Ther 1995;273:561-7.
46. Witmer C, Fana E, Park HS, Sadrieh N, Yurkow E, O'Connell S, et al. In vivo effects of chromium. Environ Health Perspect 1994;102(Suppl 3): 169-76.
47. Kobayashi Y, Yoshida T, Kotani E, Aoyagi T, Kuroiwa Y, Tobinagu S. Involvement of testosterone in the induction of hepatic microsomal cytochrome P-450 2B1/2 (P-450 2B1/2) by 1-benzylimidazole in male and female rats: sex-differentiated induction of P-450 2B1/2 species. Biochim Biophys Acta 1994;1200:11-8.
48. Sawaya ME. Biochemical mechanisms regulating human hair growth Skin Pharmacol 1994;7:5-7.
49. van de Wiel JA, Meuwissen M, Kooy H, Fijneman PH, Noordhoek J, Bos RP. Influence of long-term ethanol treatment on in vitro biotransformation of benzo(a)pyrene in microsomes of the liver, lung and small intestine from male and female rats. Biochem Pharmacol 1992;44:1977-84.
50. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3.
51. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44:833-9.
52. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin Ll, et al. Lung cancer among Chinese women. Int J Cancer 1987;40:604-9.
53. Taioli E. Wynder EL. Endocrine factors and adenocarcinoma of the lung in women [letter]. J Natl Cancer Inst 1994;86:869-70.
54. Lupulescu A. Hormones and carcinogenesis. Westport (CT): Praeger Publ, 1983:106.